The majority of FH subjects exhibited a pathogenic variant in the LDL receptor (LDLR), and 97.7% of subjects were heterozygotes; three subjects were double heterozygotes, two subjects were compound heterozygotes and one subject was homozygote. Here, LDLR is linked to familial hyperaldosteronism.